New protocol aims to speed up pancreatitis recovery
NCT ID NCT04214756
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a standard set of guidelines, called the Methodist Acute Pancreatitis Protocol (MAPP), improves care for people with acute pancreatitis. Researchers will compare outcomes like hospital stay length and discharge status before and after the protocol was put in place. About 500 adults with severe abdominal pain and high enzyme levels are included.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that following a standard care protocol improves recovery and reduces hospital stays for acute pancreatitis patients.
- What could go wrong
- This is an observational registry study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all hospitals or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2014
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients diagnosed with acute pancreatitis beginning August 2011 at MDMC, MCMC, MMMC, and MRMC will be included in the registry for analysis of baseline and clinical outcomes data and subsequently divided into two groups (i.e. those treated pre-MAPP and post-MAPP).
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Presented to ER with Acute severe pain for \< 48 hours before presentation. * Laboratory values of Lipase and/or amylase \> 3X normal Exclusion Criteria: * History of recent penetrating or blunt abdominal trauma * Patients transferred to MDMC for upper abdominal pain consistent with pancreatic etiology
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute pancreatitis (AP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Health System
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tailored fluid dosing tame pancreatitis?
- Stomach lining may hold clues to pancreatitis outcomes
- Could a back injection ease the need for life support in pancreatitis?
- Cooling the pancreas from the inside: a new device aims to tame severe inflammation
- Hospital stay for mild pancreatitis questioned: home care as safe?
- Can a simple score predict pancreatitis death in seniors?